Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Wilder

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Clinical implications of incorporating heterogeneity corrections in mantle field irradiationSteven M Kirsner, Rajat J Kudchadker, Karl L Prado, et al.
The Journal of Urology|November 11, 2005
Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictorsJoseph P Brooks, Paul S Albert, Richard B Wilder, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|July 2, 2021
Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancerCasey Liveringhouse, Austin Sim, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2009
A prospective study of intrafraction prostate motion in the prone vs. supine positionRichard B Wilder, Lucy Chittenden, Albert V Mesa, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 23, 2015
Dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with high-dose-rate brachytherapy for large prostate volumesGeorge Yang, Tobin J Strom, Richard B Wilder, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Cancer|February 22, 2002
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphomaRichard B Wilder, Jorge E Romaguera, Susan L Tucker, et al.
Brachytherapy|November 26, 2013
High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomyTobin J Strom, Richard B Wilder, Daniel C Fernandez, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective studyChul S Ha, Joseph S Kong, Susan L Tucker, et al.
Seminars in Oncology|December 16, 2014
Altered fractionation schedules in radiation treatment: a reviewKamran A Ahmed, Candace R Correa, Thomas J Dilling, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Clinical implications of incorporating heterogeneity corrections in mantle field irradiationSteven M Kirsner, Rajat J Kudchadker, Karl L Prado, et al.
The Journal of Urology|November 11, 2005
Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictorsJoseph P Brooks, Paul S Albert, Richard B Wilder, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|July 2, 2021
Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancerCasey Liveringhouse, Austin Sim, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2009
A prospective study of intrafraction prostate motion in the prone vs. supine positionRichard B Wilder, Lucy Chittenden, Albert V Mesa, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 23, 2015
Dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with high-dose-rate brachytherapy for large prostate volumesGeorge Yang, Tobin J Strom, Richard B Wilder, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Cancer|February 22, 2002
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphomaRichard B Wilder, Jorge E Romaguera, Susan L Tucker, et al.
Brachytherapy|November 26, 2013
High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomyTobin J Strom, Richard B Wilder, Daniel C Fernandez, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective studyChul S Ha, Joseph S Kong, Susan L Tucker, et al.
Seminars in Oncology|December 16, 2014
Altered fractionation schedules in radiation treatment: a reviewKamran A Ahmed, Candace R Correa, Thomas J Dilling, et al.
Pageof 5